NDC 65977-220 - HYDRALAZINE HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 65977-220
- Package NDCs from labels
- 65977-220-10, 65977-220-50, 65977-220-01
- Manufacturer
- Rebel Distributors Corp
- Effective date
- 2011-01-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HYDRALAZINE HYDROCHLORIDE - Rebel Distributors Corp | Rebel Distributors Corp | 2011-01-17 | HUMAN PRESCRIPTION DRUG LABEL |
| HYDRALAZINE HYDROCHLORIDE - HETERO DRUGS LIMITED | HETERO DRUGS LIMITED | 2008-09-19 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65977-220-01 | HYDRALAZINE HYDROCHLORIDE | 1000 in 1 BOTTLE | TABLET | 1000 | 1 | |
| 65977-220-10 | HYDRALAZINE HYDROCHLORIDE | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 65977-220-50 | HYDRALAZINE HYDROCHLORIDE | 500 in 1 BOTTLE | TABLET | 500 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | d9892176-d4a6-4edb-92b9-5f56243f3d22 | 2016-06-13 | Warnings, Adverse reactions | 905222 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | ddbbdb09-3202-42d7-bbb0-08331dde2f54 | 2016-02-29 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
| d0a368ef-a524-4eb4-b984-5ee1d9d5a93d | e9888fe1-a2ed-41b5-b5dd-df7fff3fad37 | 2011-01-17 | Warnings, Adverse reactions | d0a368ef-a524-4eb4-b984-5ee1d9d5a93d e9888fe1-a2ed-41b5-b5dd-df7fff3fad37 | ||
| 46F13307-7260-0715-CC8E-679B585D85FA | a2b73026-2451-406f-b866-9dc16177cb44 | 2008-09-19 | Warnings, Adverse reactions | 46F13307-7260-0715-CC8E-679B585D85FA a2b73026-2451-406f-b866-9dc16177cb44 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.